熱門:

搜尋結果

共 2023 個結果
頁數:1...45 46 47 48 49 50 51 52 53 ...102

開拓藥業-B(09939) 其他-業務發展最新情況

開拓藥業-B(09939) 自願公告 普克魯胺治療COVID-19重症患者的臨床試驗結果(140KB, pdf ...全文

即時新聞港交所通告2021年03月11日

Time for government to set up Science and Development Office

... ce of the Covid-19 global crisis has highlighted the importance of scientific research. Healthcare, vaccination, testing and protective equipment are all about science, while there is increasing relia ...More

EJ Insight2021-03-10

The US recovery’s promising moment

President Joe Biden’s announcement that the US will have enough COVID-19 vaccines for every American by the end of May has contributed to a rising tide of optimism about the country’s economic prospec ...More

EJ Insight2021-03-10

The bitcoin lottery

... a year of COVID-19 lockdowns. To be sure, in some cases, pursuing the SPAC route to a healthy return probably makes a lot of sense. But the fact that so many of these entities are being created should ...More

EJ Insight2021-03-09

On vaccine politics, public communication and political efficacy

... pute of a COVID-19 response that has been lackluster – ...全文

今日信報時事評論EJ InsightBrian2021年03月09日

On vaccine politics, public communication and political efficacy

... pute of a COVID-19 response that has been lackluster – to say the least. Indeed, those who oppose the government’s COVID-19 response have cited isolated incidents – e.g. the passing of the 63yo man in ...More

EJ Insight2021-03-08

Data infrastructure fundamental to HK's innotech development

... uring the Covid-19 epidemic, one of them is leaking sewer pipes in “three-nil” buildings, that is, buildings without owners' corporations, residents organizations, nor management companies which has a ...More

EJ Insight2021-03-08

大嶼山人想要怎樣的明日大嶼?

... 重要。 就以過去一年COVID-19肆虐下的離島遊熱潮為例,由於市民不能外遊,大嶼山成為不少人假日到訪的選擇, ...全文

今日信報時事評論龍子維2021年03月08日

從疫苗到通脹看科技股大跌

... h公司合作成功開發了COVID-19疫苗。 資金充裕有利創新 除了輝瑞,沒有一間主流疫苗製造商能脫穎而出,原因 ...全文

今日信報理財投資財經coffee陸永2021年03月06日

開拓藥業-B(09939) 其他-業務發展最新情況

開拓藥業-B(09939) 自願公告 普克魯胺治療COVID-19的III期臨床試驗獲美國食品和藥物管理局(F ...全文

即時新聞港交所通告2021年03月05日

小兒麻痹症的啟示(下)

小兒麻痹症以攻擊脊椎的神經元來阻擋中樞神經系統與肌肉的傳遞,導致患者窒息,與我們現在經歷的COVID-19攻擊 ...全文

今日信報副刊文化視線所及李衍蒨2021年03月03日

英國解鎖時間表

... 西南偏僻一角,是英國COVID-19傷亡數字較低的地區之一。工業革命期間,該區經濟主要來自銅鐵礦,今日除了旅遊 ...全文

今日信報副刊文化酒食浪遊劉群章2021年03月03日

New round of jab bookings

In the latest round of jab arrangement, citizens in the priority groups can make online bookings to receive the COVID-19 vaccine from March 3, the Government said Monday. They can arrange to receive t ...More

EJ Insight2021-03-02

Realizing the silver lining of the pandemic

In “The Great Realisation,” a compelling four-minute video, the poet Tomos Roberts (aka Tom Foolery) suggests a potential silver lining to the COVID-19 cataclysm. By forcing us to slow down, literally ...More

EJ Insight2021-03-02

為何美國應該追求與華合作

... 回歸多邊主義,該國的COVID-19抗議工作一團糟,在1月20日之前一直積極與減輕氣候變化的措施作對。拜登政府 ...全文

今日信報時事評論Jeffrey D. Sachs2021年03月02日

Winning the COVID vaccination race: India’s case

... approve a COVID-19 vaccine for emergency use, and the stumbles to get supplies distributed in the United States and the European Union. But for those seeking lessons on how to protect a population thr ...More

EJ Insight2021-03-01

一危俱危

... 治療和診斷」,以抗擊COVID-19。只是將口頭意願轉變為實際行動需要果斷的國內政治領導,以及對發展中國家大大 ...全文

今日信報時事評論埃利安2021年02月27日

緬甸軍事政變後的中緬關係

... 年退休,昂山素姬處理COVID-19疫情又得到緬甸人民認可,民眾對她的政治前途期望甚殷,使NLD在去年11月大 ...全文

今日信報時事評論黃伯農2021年02月27日

抗疫體現大國擔當

... 地區管理着全球可用的Covid-19疫苗供應的75%,而130多個國家甚至沒有接收過第一劑疫苗。中國外長王毅曾 ...全文

今日信報時事評論周伯展2021年02月27日

Telling the fortune of digital payments in 2021

Just over one year into the COVID-19 pandemic, it has been impossible to ignore the stratospheric growth of digital payment methods across the world. In APAC specifically, we’ve seen Facebook and PayP ...More

EJ Insight2021-02-26

頁數:1...45 46 47 48 49 50 51 52 53 ...102

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。